Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
- PMID: 19330027
- PMCID: PMC2748125
- DOI: 10.1038/ng.354
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
Abstract
Genome-wide association studies (GWAS) have identified seven breast cancer susceptibility loci, but these explain only a small fraction of the familial risk of the disease. Five of these loci were identified through a two-stage GWAS involving 390 familial cases and 364 controls in the first stage, and 3,990 cases and 3,916 controls in the second stage. To identify additional loci, we tested over 800 promising associations from this GWAS in a further two stages involving 37,012 cases and 40,069 controls from 33 studies in the CGEMS collaboration and Breast Cancer Association Consortium. We found strong evidence for additional susceptibility loci on 3p (rs4973768: per-allele OR = 1.11, 95% CI = 1.08-1.13, P = 4.1 x 10(-23)) and 17q (rs6504950: per-allele OR = 0.95, 95% CI = 0.92-0.97, P = 1.4 x 10(-8)). Potential causative genes include SLC4A7 and NEK10 on 3p and COX11 on 17q.
Figures



References
-
- Stacey SN, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39:865–869. - PubMed
-
- Stacey SN, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40:703–706. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 CA69417/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- U01 CA069467/CA/NCI NIH HHS/United States
- CA67262/CA/NCI NIH HHS/United States
- R01 CA102740-01A2/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- U01 CA069417/CA/NCI NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- U01 CA069638/CA/NCI NIH HHS/United States
- 5UO1CA098233/CA/NCI NIH HHS/United States
- C490/A11021/CRUK_/Cancer Research UK/United Kingdom
- A10123/CRUK_/Cancer Research UK/United Kingdom
- P01 CA087969/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- R01 CA058860/CA/NCI NIH HHS/United States
- CA87969/CA/NCI NIH HHS/United States
- U01 CA069398/CA/NCI NIH HHS/United States
- K07 CA092044/CA/NCI NIH HHS/United States
- CA49449/CA/NCI NIH HHS/United States
- 19275/CRUK_/Cancer Research UK/United Kingdom
- R01 CA104021/CA/NCI NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- R01 CA065725/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- 11021/CRUK_/Cancer Research UK/United Kingdom
- UO1 CA69467/CA/NCI NIH HHS/United States
- U01 CA069631/CA/NCI NIH HHS/United States
- U01 CA69398/CA/NCI NIH HHS/United States
- U01 CA098233/CA/NCI NIH HHS/United States
- U01 CA69638/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- C1287/A7497/CRUK_/Cancer Research UK/United Kingdom
- U01 CA058860/CA/NCI NIH HHS/United States
- CA-92044/CA/NCI NIH HHS/United States
- CA-06-503/CA/NCI NIH HHS/United States
- U01 CA69446/CA/NCI NIH HHS/United States
- U01 CA69631/CA/NCI NIH HHS/United States
- CA-95-011/CA/NCI NIH HHS/United States
- R01 CA122340/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- UO1 CA098710/CA/NCI NIH HHS/United States
- P30 CA062203/CA/NCI NIH HHS/United States
- CA50385/CA/NCI NIH HHS/United States
- CA-58860/CA/NCI NIH HHS/United States
- U01 CA049449/CA/NCI NIH HHS/United States
- U01 CA069446/CA/NCI NIH HHS/United States
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- U01 CA69467/CA/NCI NIH HHS/United States
- U01 CA098710/CA/NCI NIH HHS/United States
- C1287/A5260/CRUK_/Cancer Research UK/United Kingdom
- CA65725/CA/NCI NIH HHS/United States
- R01 CA102740/CA/NCI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- 2004NOV49/BBC_/Breast Cancer Now/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases